Stool transplant as treatment in ulcerative colitis

Phase 2

• Conditions: Health Condition 1: K51- Ulcerative colitisHealth Condition 2: null- Ulcerative Colitis in Remission

• Registration Number: CTRI/2018/02/012148
• Lead Sponsor: Arshdeep Singh

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Confirmed Ulcerative Colitis patients who are in clinical remission (defined as complete resolution of symptoms) for a minimum duration of 6 months.

2. Patients must be on stable medication regimen for at least 6 months prior to enrollment.

3. Able to give informed consent and/or assent as appropriate

Exclusion Criteria

1. Patients with active disease

2. Patients having toxic megacolon

3. Treatment naïve patients

4. Pregnant and lactating ladies

5. Prior colectomy

6. Positive stool test for any of the following: Clostridium difficile, Salmonella, Shigella, Yersinia, Campylobacter, E. coli by standard stool culture.

7. Regular probiotic supplement use within prior 4 weeks to enrollment

8. Severe immunodeficiency, inherited or acquired (e.g. HIV, chemotherapy, or radiation therapy)

9. Patients unwilling or unable to give consent or participate in all study requirements

Study & Design

• Study Type: Interventional
• Study Design: Not specified